Author

Mimi Guebre-Xabier

Novavax Inc., Gaithersburg, Maryland, USA

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adrianus C. M. BooniD· 1 shared Astha JoshiiD· 1 shared Gale SmithiD· 1 shared Michael S. Diamond· 1 shared Nadia Soudani· 1 shared Nita PateliD· 1 shared Suzanne M. ScheafferiD· 1 shared Traci L. BrickeriD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adrianus C. M. BoonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivAug 7, 2023

NVX-CoV2373 ancestral and NVX-CoV2540 BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters

Traci L. Bricker, Astha Joshi, Nadia Soudani…·Adrianus C. M. Boon

This study evaluates the efficacy of NVX-CoV2373 and NVX-CoV2540 nanoparticle vaccines against the Omicron BA.5 variant in Syrian hamsters, showing reduced viral infection and better protection compared to mRNA vaccines.

DOI 10.1128/jvi.01206-23

mouseexperimental assay

𝕏 PostBluesky